You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Recombinant Subunit Vaccine/Prevention of West Nile Vir*

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): West Nile virus infection is an emerging infectious disease in the United States. The virus infects birds, which serve as the natural reservoir for the virus, in addition to humans and horses which are incidental h

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Kinetic Biomarker for CLL Prognosis

    SBC: KINEMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant) PHASE I The need for reliable biomarkers in cancer is clear, for areas including prognosis, stratification, therapeutic monitoring and drug discovery and approval. The fundamental disorder in cancer is altered cell k

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Human PSMA MAb Radioimmunotherapy for Prostate Cancer

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, almost all prostate carcinomas eventuall

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Development of PSMA-based recombinant protein vaccines

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most common cancer of men in the United States with approximately 189,000 new cases and 30,000 deaths in 2002. Recurrent disease can be controlled temporarily with androgen ablation. However, alm

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Producing Polyclonal Human Antibodies to Anthrax

    SBC: HEMATECH, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Anthrax is a high risk bioterrorist threat. Despite high dose antibiotic therapy, several deaths occurred following the 2001 mail attack. Passive immunization with anti-anthrax immunoglobulins, in combination with

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Islet Transplantation with Chimeric Donor Pigs

    SBC: XIMEREX, INC.            Topic: N/A

    More than 1 million Americans have type I (insulin dependent) diabetes. Transplantation of human islets, with the appropriate immune suppression, can provide a long-term insulin free cure. However, there is a severe shortage of human islet donors availabl

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Technology for Culture of Megathura crenulata for KLH

    SBC: Stellar Biotechnologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The continuing goal of this project is to produce reliable and large-scale supplies of medical grade, quality-controlled Keyhole Limpet Hemocyanin (KLH) products ready for use in an expanding array of cancer vacci

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. A Rapid Method for HLA-typing by Haplotyping

    SBC: GENERATION BIOTECH, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Identification of Human Leukocyte Antigens, HLA, for matching of kidney and bone marrow donors and recipients is mandatory for transplantation. Many allele combinations fail to be resolved with current typing methods.

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Potentiating an Anthrax DNA Vaccine with Electroporation

    SBC: ICHOR MEDICAL SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Anthrax, an infectious disease caused by Bacillus anthracis, became a pressing concern because of its potential biowarfare use, most likely via aerosolized anthrax spore dissemination, resulting in deadly inhalation a

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Could Dedicated Breast PET Predict Multifocality?

    SBC: NAVISCAN PET SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A two-phase study is planned to validate whether functional breast imaging with a dedicated breast PET device could detect and confirm breast cancer multifocality and/or multicentricity prior to surgery. Surgeons ar

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government